Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines

Background/Aim: Pancreatic ductal adenocarcinoma (PDA) remains one of the most aggressive tumors with a dismally poor prognosis. Although surgical resection remains the only potentially curative treatment, most PDAs are not surgically resectable at diagnosis. Therefore, multimodal therapy is urgentl...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Shuichi Hanada, Tomoko Tsuruta, Kouichi Haraguchi, Masato Okamoto, Haruo Sugiyama, Shigeo Koido
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Taylor & Francis Group 2019-02-01
Ráidu:Human Vaccines & Immunotherapeutics
Fáttát:
pancreatic cancer
wt1
dendritic cell
multimodal therapy
vaccine
Liŋkkat:http://dx.doi.org/10.1080/21645515.2018.1524238

Interneahtta

http://dx.doi.org/10.1080/21645515.2018.1524238

Geahča maid